Pharmacy Benefits Management Services Home

In the PROVE-IT study, 4162 patients hospitalized with acute coronary syndrome were randomized to receive pravastatin 40 mg or atorvastatin 80 mg and followed for 18-36 months (mean 24 months). (Acute CAD) The primary endpoint was a composite of all cause death, MI, documented unstable angina requiring hospitalization, revascularization or stroke. ................
................